Title : Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells.

Pub. Date : 2021 Aug

PMID : 34281834






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MATERIALS AND METHODS: Parental human CRPC cell line PC3 (PC3/P) was continuously exposed to increasing doses of docetaxel, and a cell line resistant to docetaxel, PC3/R, was developed. Docetaxel proprotein convertase subtilisin/kexin type 1 Homo sapiens
2 MATERIALS AND METHODS: Parental human CRPC cell line PC3 (PC3/P) was continuously exposed to increasing doses of docetaxel, and a cell line resistant to docetaxel, PC3/R, was developed. Docetaxel proprotein convertase subtilisin/kexin type 1 Homo sapiens
3 MATERIALS AND METHODS: Parental human CRPC cell line PC3 (PC3/P) was continuously exposed to increasing doses of docetaxel, and a cell line resistant to docetaxel, PC3/R, was developed. Docetaxel proprotein convertase subtilisin/kexin type 1 Homo sapiens
4 Furthermore, additional treatment of PC3/R with a specific inhibitor of AKT significantly enhanced the cytotoxic activity of docetaxel but not that of cabazitaxel. Docetaxel proprotein convertase subtilisin/kexin type 1 Homo sapiens